Incorporating AI into medical terminology software can significantly enhance the precision of clinical documentation, medical classification, and other healthcare-related tasks. Artificial intelligence algorithms can analyze enormous quantities of medical data, recognize patterns, and make accurate predictions. Moreover, AI can assist in the market opportunity by reducing manual labour and automating routine tasks. As an illustration, artificial intelligence (AI) can aid in extracting relevant medical codes and terms from clinical notes, enabling healthcare professionals to allocate their time to other critical obligations.
Stringent regulatory frameworks, like the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in Europe, mandate secure and standardized handling of healthcare data. This plays a pivotal role in ensuring compliance with these regulations. The paradigm shifts towards precision medicine, where therapies are tailored to particular patients based on their unique genetic makeup, demands advanced medical terminology software capable of accurately deciphering complex genetic and molecular information.
The European Union's eHealth Action Plan emphasizes using digital technologies in healthcare. As per the National Statistics of the UK, in 2020, present healthcare expenditures in the United Kingdom amounted to £257.6 billion, equivalent to £3,840 per individual. In 2020, the aggregate current healthcare expenditure in the United Kingdom comprised 12.0% of the country's gross domestic product (GDP), up from 9.9% in 2019. The UK's healthcare system is increasingly focused on achieving interoperability between healthcare systems and providers. It is key in achieving standardized communication and data exchange, supporting seamless interoperability. Therefore, the factors mentioned above will propel the market growth in this region.
The Germany market dominated the Europe Medical Terminology Software Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $126.2 Million by 2030. The UK market is exhibiting a CAGR of 9.2% during (2023 - 2030). Additionally, The France market would experience a CAGR of 10.9% during (2023 - 2030).
Based on Application, the market is segmented into Quality Reporting, Reimbursement, Data Aggregation, Clinical Trials and Others. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Wolters Kluwer N.V.
- Intelligent Medical Objects, Inc.
- Clinical Architecture, LLC
- B2i Healthcare Kft
- HiveWorx Limited
- 3M Company
- West Coast Informatics, Inc.
- TermSolutions GmbH
- BITAC, Inc.
- Apelon, Inc.
Market Report Segmentation
By Application- Quality Reporting
- Reimbursement
- Data Aggregation
- Clinical Trials
- Others
- Healthcare Providers
- Healthcare Payers
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Companies Mentioned
- Wolters Kluwer N.V.
- Intelligent Medical Objects, Inc.
- Clinical Architecture, LLC
- B2i Healthcare Kft
- HiveWorx Limited
- 3M Company
- West Coast Informatics, Inc.
- TermSolutions GmbH
- BITAC, Inc.
- Apelon, Inc.
Methodology
LOADING...